A Study of LY3039478 in Participants With Advanced or Metastatic Solid Tumors
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Solid Tumor|Breast Cancer|Colon Cancer|Cholangiocarcinoma|Soft Tissue Sarcoma
Interventions: DRUG: LY3039478|DRUG: Taladegib|DRUG: Abemaciclib|DRUG: Cisplatin|DRUG: Gemcitabine|DRUG: Carboplatin|DRUG: LY3023414
Sponsor: Eli Lilly and Company